National Institute for Health and Care Excellence

Awaiting development: Guidance and quality standards

Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624] Technology appraisal guidance Zolbetuximab with ...
National Institute for Health and Care Excellence

Awaiting development: Guidance and quality standards

Allo-APZ2-EB for treating dystrophic and junctional epidermolysis bullosa in people of any age [ID6746] Technology appraisal guidance Alpelisib for treating severe PIK3CA-related overgrowth spectrum ...